Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease | Zendy

Sullivan Kelly L. | Zendy; Staffetti Joseph F. | Zendy; Hauser Robert A. | Zendy; Dunne Peter B. | Zendy; Zesiewicz Theresa A. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease

Author(s) -

Sullivan Kelly L.,

Staffetti Joseph F.,

Hauser Robert A.,

Dunne Peter B.,

Zesiewicz Theresa A.

Publication year - 2006

Publication title -

movement disorders

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.352

H-Index - 198

eISSN - 1531-8257

pISSN - 0885-3185

DOI - 10.1002/mds.20666

Subject(s) - constipation , tegaserod , medicine , parkinson's disease , placebo , disease , defecation , physical therapy , alternative medicine , pathology

We performed a double‐blind randomized placebo‐controlled pilot study to determine the efficacy of tegaserod (Zelnorm) in treating constipation in 15 patients with Parkinson's disease (PD). There was a trend for improvement in the Subject's Global Assessment (SGA) of satisfaction with bowel habits (NS) and the total SGA (including abdominal discomfort, bothersome constipation, and satisfaction; NS). © 2005 Movement Disorder Society

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research